Skip to Content
Merck
  • Cutaneous necrobiotic xanthogranuloma (NXG)--successfully treated with low dose chlorambucil.

Cutaneous necrobiotic xanthogranuloma (NXG)--successfully treated with low dose chlorambucil.

European journal of dermatology : EJD (2001-08-30)
S Machado, R Alves, M Lima, I Leal, A Massa
ABSTRACT

We report a case of necrobiotic xanthogranuloma in a 51 year-old white male patient presenting with a 6-year history of multiple indurated violaceous nodules and plaques involving the eyelids, trunk and extremities. He had an associated paraproteinemia (Ig G lambda), elevated sedimentation rate, cryoglobulinemia and hypocomplementemia. No extracutaneous involvement was detected. He was successfully treated with chlorambucil (2 mg/d for 7 months), leading to disappearance of all skin lesions.

MATERIALS
Product Number
Brand
Product Description

Chlorambucil, European Pharmacopoeia (EP) Reference Standard
SKU
Pack Size
Availability
Price
Quantity
Chlorambucil for system suitability, European Pharmacopoeia (EP) Reference Standard
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Chlorambucil
SKU
Pack Size
Availability
Price
Quantity